These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30580464)

  • 21. 'I had a bigger cancer risk than I thought…': The experience of receiving personalized risk information as part of a skin cancer prevention intervention in the college setting.
    Brady HL; Hamilton JG; Kaphingst KA; Jensen JD; Kohlmann W; Parsons BG; Lillie HM; Wankier AP; Smith HJ; Grossman D; Hay JL; Wu YP
    Health Expect; 2022 Dec; 25(6):2937-2949. PubMed ID: 36225123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Melanoma high-risk families' perceived health care provider risk communication.
    Loescher LJ; Crist JD; Cranmer L; Curiel-Lewandrowski C; Warneke JA
    J Cancer Educ; 2009; 24(4):301-7. PubMed ID: 19838889
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sun protection practices among offspring of women with personal or family history of skin cancer.
    Geller AC; Brooks DR; Colditz GA; Koh HK; Frazier AL
    Pediatrics; 2006 Apr; 117(4):e688-94. PubMed ID: 16585282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Personalized melanoma risk assessments and tailored prevention advice: a pragmatic randomized controlled trial in Australian general practice.
    Vuong K; Armstrong BK; McGeechan K; Cust AE
    Fam Pract; 2019 Mar; 36(2):237-246. PubMed ID: 29800131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk attitudes and sun protection behaviour: Can behaviour be altered by using a melanoma genomic risk intervention?
    Morton RL; Asher R; Peyton E; Tran A; Smit AK; Butow PN; Kimlin MG; Dobbinson SJ; Wordsworth S; Keogh L; Cust AE
    Cancer Epidemiol; 2019 Aug; 61():8-13. PubMed ID: 31102918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of melanoma diagnosis on sun-awareness and protection: efficacy of education campaigns in a high-risk population.
    Freiman A; Yu J; Loutfi A; Wang B
    J Cutan Med Surg; 2004; 8(5):303-9. PubMed ID: 15868284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes of a Randomized Controlled Trial of Genomic Counseling for Patients Receiving Personalized and Actionable Complex Disease Reports.
    Sweet K; Sturm AC; Schmidlen T; McElroy J; Scheinfeldt L; Manickam K; Gordon ES; Hovick S; Scott Roberts J; Toland AE; Christman M
    J Genet Couns; 2017 Oct; 26(5):980-998. PubMed ID: 28345121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting Australian adults' sun-safe behaviour: examining the role of personal and social norms.
    White KM; Starfelt LC; Young RM; Hawkes AL; Leske S; Hamilton K
    Br J Health Psychol; 2015 May; 20(2):396-412. PubMed ID: 24917299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. "I remember how I felt, but I don't remember the gene": Families' experiences of cancer-related genetic testing in childhood.
    McGill BC; Wakefield CE; Vetsch J; Lim Q; Warby M; Metcalfe A; Byrne JA; Cohn RJ; Tucker KM
    Pediatr Blood Cancer; 2019 Aug; 66(8):e27762. PubMed ID: 31006986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Family risk discussions after feedback on genetic risk of melanoma.
    Hay JL; Gordon M; Li Y
    JAMA Dermatol; 2015 Mar; 151(3):342-3. PubMed ID: 25337828
    [No Abstract]   [Full Text] [Related]  

  • 31. Better the devil you know? High-risk individuals' anticipated psychological responses to genetic testing for melanoma susceptibility.
    Kasparian NA; Meiser B; Butow PN; Job RF; Mann GJ
    J Genet Couns; 2006 Dec; 15(6):433-47. PubMed ID: 17103321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pediatric Predispositional Genetic Risk Communication: Potential Utility for Prevention and Control of Melanoma Risk as an Exemplar.
    Wu YP; Mays D; Kohlmann W; Tercyak KP
    J Genet Couns; 2017 Oct; 26(5):887-893. PubMed ID: 28547663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Systematic Review on the Impact of Genetic Testing for Familial Melanoma I: Primary and Secondary Preventative Behaviours.
    Primiero CA; Yanes T; Finnane A; Soyer HP; McInerney-Leo AM
    Dermatology; 2021; 237(5):806-815. PubMed ID: 33588421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perceived intrafamily melanoma risk communication.
    Loescher LJ; Crist JD; Siaki LA
    Cancer Nurs; 2009; 32(3):203-10. PubMed ID: 19295423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized trial to improve early detection and prevention practices among siblings of melanoma patients.
    Geller AC; Emmons KM; Brooks DR; Powers C; Zhang Z; Koh HK; Heeren T; Sober AJ; Li F; Gilchrest BA
    Cancer; 2006 Aug; 107(4):806-14. PubMed ID: 16832795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Communicating cancer risk within an African context: experiences, disclosure patterns and uptake rates following genetic testing for Lynch syndrome.
    Bruwer Z; Futter M; Ramesar R
    Patient Educ Couns; 2013 Jul; 92(1):53-60. PubMed ID: 23453851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new approach to assessing affect and the emotional implications of personal genomic testing for common disease risk.
    O'Neill SC; Tercyak KP; Baytop C; Hensley Alford S; McBride CM
    Public Health Genomics; 2015; 18(2):104-12. PubMed ID: 25612474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systematic review of psychosocial outcomes for patients with advanced melanoma.
    Dunn J; Watson M; Aitken JF; Hyde MK
    Psychooncology; 2017 Nov; 26(11):1722-1731. PubMed ID: 27696578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does enhanced information at cancer genetic counseling improve counselees' knowledge, risk perception, satisfaction and negotiation of information to at-risk relatives?--a randomized study.
    Roshanai AH; Rosenquist R; Lampic C; Nordin K
    Acta Oncol; 2009; 48(7):999-1009. PubMed ID: 19636983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does experience predict knowledge and behavior with respect to cutaneous melanoma, moles, and sun exposure? Possible outcome measures.
    Jackson A; Wilkinson C; Hood K; Pill R
    Behav Med; 2000; 26(2):74-9. PubMed ID: 11147292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.